BCL2 and skin basal cell carcinoma: Meanwhile, a very promising outcome has been achieved in the control of the growth and proliferation of breast cancer cells (BCC), where both nuclear and cytosolic targeting seemed capable of activating programmed cell death (PCD) pathways by a change in the expression profile of regulatory proteins, e.g., bcl-2 protein family [8,17].